Learn more

MESSADEK JALLAL

Overview
  • Total Patents
    66
  • GoodIP Patent Rank
    230,058
About

MESSADEK JALLAL has a total of 66 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, environmental technology and machines are AMMON HERMANN P T, CELLULAR SCIENCES INC and VIROTEX CORP.

Patent filings per year

Chart showing MESSADEK JALLALs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Messadek Jallal 49
#2 Gharbi Abderrahmane 4
#3 Ennamany Rachid 2
#4 Abid Abdelaziz 1
#5 Thiry Michel 1

Latest patents

Publication Filing date Title
WO2021078412A1 Fractal formulations
WO2009065193A1 Treatment of aspirin resistance with betaine and/or betaine enriched molasses
EP2244704A1 Treatment of aspirin resistance with betaine and/or betaine enriched molasses
WO2008009071A2 Combination therapy using betaine and endothelin antagonists
MX2007013486A Insulins combinations.
US2006128657A1 Selected betaines and their uses
US2006160896A1 Therapeutic treatment
WO2006086856A1 Combination therapeutic compositions and method of use
WO2006050581A2 Betaine as agent against arthropod - or mosquito -borne diseases
WO2005011645A2 Selected betaines and their uses
EP1660070A2 Selected betaines and their uses
BE1016128A6 Combination therapy
EP1615632A1 Floating oral formulations for controlled release of betaine
US7608640B2 Glycine betaine and its use
BE1015608A6 TREATMENT arteritis.
US2006233877A1 Betaine compositions
CA2441948A1 Glycine betaine and its use as anti-hemorrhagic agent
BE1014097A6 Addition of a betaine to a contrast agent reduces side effects, especially in cardiovascular investigations
BE1013958A6 Pharmaceutical combination useful in the treatment of thrombosis comprises a therapeutic active agent with at least one hemorrhagic side effect and a glycine betaine
BE1012712A6 Antithrombotic peptides